Nuvation Bio Inc. (NUVB) Tops Q3 EPS by 2c

Nuvation Bio Inc. (NYSE: NUVB) reported Q3 EPS of ($0.09), $0.02 better than the analyst estimate of ($0.11).

For earnings history and earnings-related data on Nuvation Bio Inc. (NUVB) click here.

You May Also Be Interested In

• North American Construction (NOA) Tops Q2 EPS by 9c; Offers Guidance
• CAE, Inc. (CAE) Tops Q1 EPS by 2c, Beats on Revenue; Offers FY27 EPS Guidance
• Aptera Motors (SEV) Reports Q2 Loss of $0.20